Skip to content
Archives:

REGISTER HERE
January 28, 2026
8:00 am, EST

New tuberculosis (TB) vaccines could be realized as soon as 2028 — radically reshaping the journey to eliminate TB. Communities and civil society organizations are poised to play a vital role in the introduction of a future TB vaccine as central protagonists of this next chapter for TB elimination.

TAG’s forthcoming report, What Could Go Right? Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines, explores the foundational role that community and civil society groups can play in the successful introduction of a new TB vaccine and strategies for capacitating and empowering communities towards that goal. In bringing together three unique sub-studies, this first-of-its-kind report examines community and civil society’s readiness to engage in TB vaccine advocacy and policymaking at national, regional, and global levels, and underscores the transformative role communities can play in TB vaccine introduction, as well as the critical need for other stakeholders to help them realize that potential.

Please join us to discuss What Could Go Right? Partnering with Communities and Civil Society for New TB Vaccine and the path forward to capacitating and engaging community and civil society in the preparation for and introduction of a future TB vaccine. The webinar will feature presentations showcasing:

  • results of a global survey of TB community and civil society organizations and their readiness to engage in TB vaccine policy making;
  • country policy portraits — a new tool for advocates to learn about how national immunization policy is made in their countries; and
  • an access roadmap charting the actions civil society can take to ensure equitable access to new TB vaccines.

Moderator:
Mike Frick, TB Project Co-Director, Treatment Action Group

Presenters:

  • Erin McConnell, Senior TB Project Associate, Treatment Action Group
  • Edna Tembo, Executive Director, Coalition of Women Living with HIV/AIDS (COWHLA)
  • Sergey Golovin, Independent Consultant on Access to Treatment

REGISTER HERE

Back To Top